Insufficient scRNA-seq data for expression of VGLL2 at single-cell level.
Insufficient scRNA-seq data for expression of VGLL2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
muscle | 100% | 4871.63 | 803 / 803 | 0% | 0 | 0 / 0 |
heart | 55% | 121.26 | 470 / 861 | 0% | 0 | 0 / 0 |
brain | 12% | 8.30 | 308 / 2642 | 15% | 0.73 | 106 / 705 |
skin | 14% | 8.19 | 258 / 1809 | 1% | 0.25 | 4 / 472 |
prostate | 7% | 12.91 | 17 / 245 | 3% | 0.22 | 17 / 502 |
ovary | 8% | 3.68 | 15 / 180 | 1% | 0.02 | 4 / 430 |
adipose | 8% | 5.44 | 100 / 1204 | 0% | 0 | 0 / 0 |
uterus | 0% | 0 | 0 / 170 | 8% | 1.74 | 35 / 459 |
tonsil | 0% | 0 | 0 / 0 | 7% | 0.73 | 3 / 45 |
adrenal gland | 0% | 0.10 | 1 / 258 | 5% | 0.33 | 12 / 230 |
esophagus | 3% | 2.26 | 49 / 1445 | 2% | 0.02 | 4 / 183 |
thymus | 2% | 2.49 | 11 / 653 | 2% | 0.09 | 12 / 605 |
lymph node | 0% | 0 | 0 / 0 | 3% | 0.06 | 1 / 29 |
lung | 1% | 0.46 | 7 / 578 | 2% | 1.15 | 21 / 1155 |
peripheral blood | 2% | 3.38 | 23 / 929 | 0% | 0 | 0 / 0 |
breast | 2% | 1.79 | 9 / 459 | 0% | 0.03 | 3 / 1118 |
liver | 0% | 0 | 0 / 226 | 2% | 0.24 | 9 / 406 |
bladder | 0% | 0 | 0 / 21 | 2% | 0.04 | 9 / 504 |
stomach | 0% | 0.08 | 1 / 359 | 1% | 0.25 | 3 / 286 |
blood vessel | 1% | 2.23 | 16 / 1335 | 0% | 0 | 0 / 0 |
pancreas | 0% | 0 | 0 / 328 | 1% | 0.15 | 2 / 178 |
intestine | 0% | 0.03 | 1 / 966 | 1% | 0.17 | 4 / 527 |
kidney | 0% | 0 | 0 / 89 | 0% | 0.01 | 4 / 901 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spleen | 0% | 0 | 0 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0007519 | Biological process | skeletal muscle tissue development |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0003713 | Molecular function | transcription coactivator activity |
GO_0005515 | Molecular function | protein binding |
Gene name | VGLL2 |
Protein name | Transcription cofactor vestigial-like protein 2 (Vgl-2) (Protein VITO1) |
Synonyms | VITO1 |
Description | FUNCTION: May act as a specific coactivator for the mammalian TEFs. May play a role in the development of skeletal muscles. |
Accessions | Q8N8G2 ENST00000326274.6 [Q8N8G2-1] ENST00000352536.7 [Q8N8G2-2] |